Prospective validation of CT based radiomic models to predict surgical and clinical outcomes in advanced epithelial ovarian cancer

A CT scan already guides treatment for ovarian cancer, but a new computing method called radiomics could extract far more information from those same images—features invisible to the human eye. Ovarian cancer is the sixth most common female cancer in the UK and one of the most lethal gynaecological cancers; only a third of women survive more than ten years. Standard treatment involves surgery and chemotherapy, but doctors struggle to predict how an individual patient will respond. Researchers at Imperial College London have developed radiomic models that analyse routine CT scans using advanced computing, potentially revealing details about tumour behaviour that current methods miss. If validated, these models could help clinicians tailor treatment plans to each patient’s specific disease, rather than relying on one-size-fits-all protocols. The study also aims to link radiomic patterns with different types of ovarian cancer, which could guide development of future targeted therapies. This is a clinical validation study—it tests whether a promising new analytical tool actually improves decision-making in practice. Success would mean more personalised, effective care for women with this aggressive cancer, without requiring any new scans or invasive procedures.